We are live on ! Find out more
PC

Promethos Capital Portfolio holdings

AUM $368M
1-Year Est. Return 27.67%
This Fund
S&P 500
This Quarter Est. Return
+0.91%
1 Year Est. Return
+27.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$2.63M
Cap. Flow
+$6.21M
Cap. Flow %
2.19%
Top 10 Hldgs %
47.87%
Holding
89
New
9
Increased
34
Reduced
3
Closed
7

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.61M
2
KMB icon
Kimberly-Clark
KMB
+$3.67M
3
GDDY icon
GoDaddy
GDDY
+$3.08M
4
NTAP icon
NetApp
NTAP
+$2.74M
5
STRL icon
Sterling Infrastructure
STRL
+$1.73M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$5.98M
2
AVGO icon
Broadcom
AVGO
+$5.41M
3
TGT icon
Target
TGT
+$4.33M
4
CIG icon
CEMIG Preferred Shares
CIG
+$563K
5
HSBC icon
HSBC
HSBC
+$116K

Sector Composition

Rank Sector Weight
1 Technology 37.11%
2 Financials 23.13%
3 Healthcare 14.43%
4 Industrials 7.99%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBX icon
51
Dropbox
DBX
$7.39B
$100K 0.04%
+3,340
New +$92.2K
PYPL icon
52
PayPal
PYPL
$52.4B
$71.3K 0.03%
+835
New +$70.2K
TGNA
53
DELISTED
TEGNA Inc
TGNA
$69.7K 0.02%
3,810
– –
CASH icon
54
Pathward Financial
CASH
$1.74B
$18.4K 0.01%
250
– –
DMC
55
Del Monte Corp
DMC
$1.47B
$16.6K 0.01%
500
– –
TMHC
56
DELISTED
Taylor Morrison
TMHC
$15.9K 0.01%
260
– –
PIPR icon
57
Piper Sandler
PIPR
$5.29B
$15K 0.01%
200
– –
JBL icon
58
Jabil
JBL
$33.8B
$14.4K 0.01%
100
– –
PBH icon
59
Prestige Consumer Healthcare
PBH
$2.45B
$14.1K 0.01%
180
– –
CBT icon
60
Cabot Corp
CBT
$4.4B
$13.7K ﹤0.01%
150
– –
CVSA
61
Covista Inc
CVSA
$4.49B
$13.6K ﹤0.01%
150
– –
PRI icon
62
Primerica
PRI
$9.26B
$13.6K ﹤0.01%
50
– –
ALX
63
Alexander's
ALX
$1.4B
$13K ﹤0.01%
65
– –
TDC icon
64
Teradata
TDC
$2.59B
$11.8K ﹤0.01%
380
– –
CVCO icon
65
Cavco Industries
CVCO
$4.6B
$11.2K ﹤0.01%
25
– –
BRC icon
66
Brady Corp
BRC
$4.33B
$11.1K ﹤0.01%
150
– –
BL icon
67
BlackLine
BL
$1.83B
$10.9K ﹤0.01%
+180
New +$10.7K
NHI icon
68
National Health Investors
NHI
$3.64B
$10.4K ﹤0.01%
+150
New +$11.4K
ARCB icon
69
ArcBest
ARCB
$3.08B
$10.3K ﹤0.01%
110
– –
SCS
70
DELISTED
Steelcase
SCS
$10.1K ﹤0.01%
60
-1,040
-95% -$13.4K
APOG icon
71
Apogee Enterprises
APOG
$869M
$10K ﹤0.01%
+140
New +$11K
VRTS icon
72
Virtus Investment Partners
VRTS
$1.11B
$9.48K ﹤0.01%
43
– –
AMG icon
73
Affiliated Managers Group
AMG
$9.39B
$9.25K ﹤0.01%
50
– –
STRL icon
74
Sterling Infrastructure
STRL
$16.3B
$8.85K ﹤0.01%
+10,000
New +$1.73M
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$16.4B
$8.62K ﹤0.01%
70
– –
1 2
3
4

Similar funds

1CP
11 Capital Partners Darien, Connecticut $368M AUM 30.26% 1-Year Est. Return
SFP
Sterling Financial Planning Sparta, New Jersey $368M AUM 22.51% 1-Year Est. Return
FZCM
Flynn Zito Capital Management Garden City, New York $368M AUM 37.57% 1-Year Est. Return
FPL
Fortress Private Ledger Raleigh, North Carolina $368M AUM 39.86% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return
NWWA
New Wave Wealth Advisors Springdale, Arkansas $367M AUM 36.16% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $368M AUM 20.94% 1-Year Est. Return
OAP
One Advisory Partners Overland Park, Kansas $367M AUM 19.94% 1-Year Est. Return

Promethos Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Promethos Capital held 89 positions worth $283M, up 0.94% from $281M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Promethos Capital's Q4 2024 filing shows 9 new, 34 increased, 3 reduced and 7 closed positions. Its largest new stake was Kimberly-Clark: 26,940 shares worth $3.53M. The largest sale was AbbVie, an estimated $5.98M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Promethos Capital's largest Q4 2024 buy was Kimberly-Clark: 26,940 shares worth $3.53M.
  • Promethos Capital added most to Bristol-Myers Squibb in Q4 2024, an estimated $4.61M increase.
  • Promethos Capital's biggest Q4 2024 reduction was CEMIG Preferred Shares, cutting an estimated $563K.
  • Promethos Capital fully exited AbbVie in Q4 2024, selling an estimated $5.98M.
  • Promethos Capital's ten largest holdings make up 48% of its $283M portfolio in Q4 2024.
  • Promethos Capital opened 9 new positions and closed 7 in Q4 2024.
  • Promethos Capital's portfolio value rose 0.94% quarter-over-quarter to $283M.

Based on Promethos Capital's 13F filing for Q4 2024, filed 13 Feb 2025.